使用理论框架探索1型糖尿病学生的症状管理经验:一种定性研究
Ny'Nika T McFadden1, Amanda H Wilkerson2, Beth H Chaney2
1Department of Health and Human Performance, Texas State University, San Marcos, Texas.
The science of diabetes self-management and care
|August 20, 2024
概括
患有1型糖尿病 (T1DM) 的大学生在管理血糖症状方面面临挑战. 观察到对低血糖的立即反应,但对高血糖的延迟反应需要进一步研究,以改善自我护理策略.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病管理 糖尿病管理
- 质量健康研究 质量健康研究
背景情况:
- 1型糖尿病 (T1DM) 需要持续的自我管理,特别是在大学生导航独特的生活方式需求.
- 现有的研究提供了有限的定性洞察力,了解这个人口中的自我护理行为和症状管理过程.
- 理论框架对于了解年轻成年人T1DM症状管理的复杂性至关重要.
研究的目的:
- 探索患有T1DM的大学生关于症状检测,解释和反应的实践经验.
- 应用慢性疾病自我护理的中程理论,以了解T1DM症状管理中的自我护理行为.
- 确定在大学环境中管理T1DM症状的具体挑战和促进者.
主要方法:
- 采用了定性描述方法,利用慢性疾病自我护理的中等范围理论作为指导框架.
- 数据是通过人口统计信息调查和半结构面试收集的,对31名被诊断患有T1DM至少两年的本科生 (18-23岁) 进行了采访.
- 在NVivo中管理的采访成绩单上进行了主题分析,以理论构造衍生的代码书为指导.
主要成果:
- 出现了三个主要主题:症状检测,症状解释和症状反应.
- 症状检测包括通过生理线索和技术监测识别血糖波动.
- 症状解释侧重于分析葡萄糖趋势和确定因果因素,而症状反应显示低血糖的迅速管理,但延迟对高血糖的反应.
结论:
- 患有T1DM的大学生在症状管理的解释和反应阶段遇到不同的挑战.
- 虽然低血糖症得到了及时的管理,但对高血糖症的延迟反应表明需要针对性的干预措施.
- 进一步的研究是必不可少的,以提高症状反应技能,并改善这一群体的整体糖尿病自我护理.
相关概念视频
Diabetes: Management and Pharmacotherapy
246
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
246
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Case Studies
11.6K
There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
11.6K
Diabetes: Symptoms, Diagnosis, and Complications
520
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Insulin: Dosing Regimen and Adverse Effects
161
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
161


